Injectable semaglutide still appears to hold an advantage for maximum average weight loss and long-term cardiovascular evidence
Granata A, Maccarrone R, Anzaldi M, Leonardi G, Pesce F, Amico F et al (2022) GLP-1 receptor agonists and renal outcomes in patients with diabetes mellitus type 2 and diabetic kidney disease: state of the art
Most people start to see results within the first month, but significant changes in weight or blood sugar levels may take a few months to become noticeable
You do not meet Medicares clinical criteria
If you are currently taking medications, have existing health conditions, are pregnant or nursing, or are considering any major changes to your health regimen, consult your physician before starting any new prescription treatment
They named it 'glucagon' (GLUCose-AGONist) on account that it seemed to be a 'glucose driving hormone' (Unger